SEARCH

SEARCH BY CITATION

REFERENCES

  • Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der Wees J, Lindeman GJ, Visvader JE. 2007. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 9: 201209.
  • Corbeil D, Roper K, Fargeas CA, Joester A, Huttner WB. 2001. Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic 2: 8291.
  • Ewald AJ, Brenot A, Duong M, Chan BS, Werb Z. 2008. Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev Cell 14: 570581.
  • Jechlinger M, Podsypanina K, Varmus H. 2009. Regulation of transgenes in three-dimensional cultures of primary mouse mammary cells demonstrates oncogene dependence and identifies cells that survive deinduction. Genes Dev 23: 16771688.
  • Johnson ET, Nicola T, Roarty K, Yoder BK, Haycraft CJ, Serra R. 2008. Role for primary cilia in the regulation of mouse ovarian function. Dev Dyn 237: 20532060.
  • Joshi PA, Jackson HW, Beristain AG, Di Grappa MA, Mote P, Clarke C, Stingl J, Waterhouse PD, Khokha R. 2010. Progesterone induces adult mammary stem cell expansion. Nature 465: 803807.
  • Karbanova J, Missol-Kolka E, Fonseca AV, Lorra C, Janich P, Hollerova H, Jaszai J, Ehrmann J, Kolar Z, Liebers C, Arl S, Subrtova D, Freund D, Mokry J, Huttner WB, Corbeil D. 2008. The stem cell marker CD133 (Prominin-1) is expressed in various human glandular epithelia. J Histochem Cytochem 56: 977993.
  • McBryan J, Howlin J, Kenny PA, Shioda T, Martin F. 2007. ERalpha-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis. Oncogene 26: 64066419.
  • McDermott KM, Liu BY, Tlsty TD, Pazour GJ. 2010. Primary cilia regulate branching morphogenesis during mammary gland development. Curr Biol 20: 731737.
  • Mizrak D, Brittan M, Alison MR. 2008. CD133: molecule of the moment. J Pathol 214: 39.
  • Oakes SR, Rogers RL, Naylor MJ, Ormandy CJ. 2008. Prolactin regulation of mammary gland development. J Mammary Gland Biol Neoplasia 13: 1328.
  • Ormandy CJ, Naylor M, Harris J, Robertson F, Horseman ND, Lindeman GJ, Visvader J, Kelly PA. 2003. Investigation of the transcriptional changes underlying functional defects in the mammary glands of prolactin receptor knockout mice. Recent Prog Horm Res 58: 297323.
  • Piazza TM, Lu JC, Carver KC, Schuler LA. 2009. SRC family kinases accelerate prolactin receptor internalization, modulating trafficking and signaling in breast cancer cells. Mol Endocrinol 23: 202212.
  • Pine SR, Ryan BM, Varticovski L, Robles AI, Harris CC. 2010. Microenvironmental modulation of asymmetric cell division in human lung cancer cells. Proc Natl Acad Sci USA 107: 21952200.
  • Roper K, Corbeil D, Huttner WB. 2000. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol 2: 582592.
  • Sekhri KK, Pitelka DR, DeOme KB. 1967. Studies of mouse mammary glands. I. Cytomorphology of the normal mammary gland. J Natl Cancer Inst 39: 459490.
  • Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK, Chadburn A, Murphy AJ, Valenzuela DM, Gale NW, Thurston G, Yancopoulos GD, D'Angelica M, Kemeny N, Lyden D, Rafii S. 2008. CD133 expression is not restricted to stem cells, and both CD133+ and CD133− metastatic colon cancer cells initiate tumors. J Clin Invest 118: 21112120.
  • Sleeman KE, Kendrick H, Ashworth A, Isacke CM, Smalley MJ. 2006. CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast Cancer Res 8: R7.
  • Sleeman KE, Kendrick H, Robertson D, Isacke CM, Ashworth A, Smalley MJ. 2007. Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J Cell Biol 176: 1926.
  • Snippert HJ, van Es JH, van den Born M, Begthel H, Stange DE, Barker N, Clevers H. 2009. Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine. Gastroenterology 136: 21872194.
  • van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R. 2002. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 19992009.
  • Weigmann A, Corbeil D, Hellwig A, Huttner WB. 1997. Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci USA 94: 1242512430.
  • Wiseman BS, Sternlicht MD, Lund LR, Alexander CM, Mott J, Bissell MJ, Soloway P, Itohara S, Werb Z. 2003. Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol 162: 11231133.
  • Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L. 2008. Brca1 breast tumors contain distinct CD44+/CD24− and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 10: R10.
  • Zacchigna S, Oh H, Wilsch-Brauninger M, Missol-Kolka E, Jaszai J, Jansen S, Tanimoto N, Tonagel F, Seeliger M, Huttner WB, Corbeil D, Dewerchin M, Vinckier S, Moons L, Carmeliet P. 2009. Loss of the cholesterol-binding protein prominin-1/CD133 causes disk dysmorphogenesis and photoreceptor degeneration. J Neurosci 29: 22972308.